Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...
Key alts deals unveiled today include Silver Point's $250 million CLO fund close, Bain Capital's stake in manufacturer Milacron, a KKR-backed tech acquisition.
The provider of highly-engineered processing equipment and solutions will sell a 51% stake in the injection molding and extrusion business for $287 million.
Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...
Bain Capital, a leading private investment firm, today announced a majority investment in the Milacron Injection Molding and Extrusion business (or the "Company"), a globally renowned provider of ...
On February 5, the company entered into a definitive agreement to sell an ownership stake of approximately 51% in its Milacron injection ...
Brookfield emerges as the third suitor for Insignia, also offering A$3.07 billion and sparking a three-way bidding war for the Aussie wealth manager.
Brookfield offered A$4.60 per share for Insignia and has been granted limited access to its books, according to a statement ...